A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer

Mack Roach, Daniel M. Chinn, John Holland, Michelle Clarke

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Purpose: To assess the impact of high dose three-dimensional conformal radiotherapy (3D CRT) for prostate cancer on the sexual function-related quality of life of patients and their partners. Methods and Materials: Sixty of 124 consecutive patients (median age 72.3 years) treated with 3D CRT for localized prostate cancer were surveyed and reported being potent prior to treatment. The answers to survey questions assessing the impact of quality of life related to sexual function from these 60 patients and their partners forms the basis for this retrospective analysis. Results: Following 3D CRT, 37 of 60 patients (62%) retained sexual function sufficient for intercourse. Intercourse at least once per month was reduced from 71 to 40%, whereas intercourse less than once per year increased from 12 to 35%. Following treatment, 25% of patients reported that the change in sexual dysfunction negatively affected their relationship or resulted in poor self-esteem. This outcome was associated with impotence following treatment (p < 0.01). Patients who had partners and satisfactory sexual function appeared to be at a higher risk of having a negatively affected relationship or losing self- esteem if they become impotent (p < 0.05). Partners of patients who reported a negatively affected relationship or loss of self-esteem appear to be less likely to return the survey instrument used (p = 0.02). Conclusions: More work is needed to evaluate the impact of radiotherapy and other treatments on the quality of life of patients and their partners to allow adequate informed consent to be given.

Original languageEnglish (US)
Pages (from-to)869-874
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume35
Issue number5
DOIs
StatePublished - Jul 15 1996
Externally publishedYes

Fingerprint

Conformal Radiotherapy
radiation therapy
Prostatic Neoplasms
cancer
Quality of Life
Self Concept
Surveys and Questionnaires
Sexual Partners
Erectile Dysfunction
Therapeutics
Informed Consent
Radiotherapy
dosage

Keywords

  • Conformal radiation therapy
  • Impotence
  • Prostate cancer
  • Quality of life
  • Sexual dysfunction

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. / Roach, Mack; Chinn, Daniel M.; Holland, John; Clarke, Michelle.

In: International Journal of Radiation Oncology Biology Physics, Vol. 35, No. 5, 15.07.1996, p. 869-874.

Research output: Contribution to journalArticle

@article{8e9f02148b854796bdfa8e07ea98be0b,
title = "A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer",
abstract = "Purpose: To assess the impact of high dose three-dimensional conformal radiotherapy (3D CRT) for prostate cancer on the sexual function-related quality of life of patients and their partners. Methods and Materials: Sixty of 124 consecutive patients (median age 72.3 years) treated with 3D CRT for localized prostate cancer were surveyed and reported being potent prior to treatment. The answers to survey questions assessing the impact of quality of life related to sexual function from these 60 patients and their partners forms the basis for this retrospective analysis. Results: Following 3D CRT, 37 of 60 patients (62{\%}) retained sexual function sufficient for intercourse. Intercourse at least once per month was reduced from 71 to 40{\%}, whereas intercourse less than once per year increased from 12 to 35{\%}. Following treatment, 25{\%} of patients reported that the change in sexual dysfunction negatively affected their relationship or resulted in poor self-esteem. This outcome was associated with impotence following treatment (p < 0.01). Patients who had partners and satisfactory sexual function appeared to be at a higher risk of having a negatively affected relationship or losing self- esteem if they become impotent (p < 0.05). Partners of patients who reported a negatively affected relationship or loss of self-esteem appear to be less likely to return the survey instrument used (p = 0.02). Conclusions: More work is needed to evaluate the impact of radiotherapy and other treatments on the quality of life of patients and their partners to allow adequate informed consent to be given.",
keywords = "Conformal radiation therapy, Impotence, Prostate cancer, Quality of life, Sexual dysfunction",
author = "Mack Roach and Chinn, {Daniel M.} and John Holland and Michelle Clarke",
year = "1996",
month = "7",
day = "15",
doi = "10.1016/0360-3016(96)00206-4",
language = "English (US)",
volume = "35",
pages = "869--874",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer

AU - Roach, Mack

AU - Chinn, Daniel M.

AU - Holland, John

AU - Clarke, Michelle

PY - 1996/7/15

Y1 - 1996/7/15

N2 - Purpose: To assess the impact of high dose three-dimensional conformal radiotherapy (3D CRT) for prostate cancer on the sexual function-related quality of life of patients and their partners. Methods and Materials: Sixty of 124 consecutive patients (median age 72.3 years) treated with 3D CRT for localized prostate cancer were surveyed and reported being potent prior to treatment. The answers to survey questions assessing the impact of quality of life related to sexual function from these 60 patients and their partners forms the basis for this retrospective analysis. Results: Following 3D CRT, 37 of 60 patients (62%) retained sexual function sufficient for intercourse. Intercourse at least once per month was reduced from 71 to 40%, whereas intercourse less than once per year increased from 12 to 35%. Following treatment, 25% of patients reported that the change in sexual dysfunction negatively affected their relationship or resulted in poor self-esteem. This outcome was associated with impotence following treatment (p < 0.01). Patients who had partners and satisfactory sexual function appeared to be at a higher risk of having a negatively affected relationship or losing self- esteem if they become impotent (p < 0.05). Partners of patients who reported a negatively affected relationship or loss of self-esteem appear to be less likely to return the survey instrument used (p = 0.02). Conclusions: More work is needed to evaluate the impact of radiotherapy and other treatments on the quality of life of patients and their partners to allow adequate informed consent to be given.

AB - Purpose: To assess the impact of high dose three-dimensional conformal radiotherapy (3D CRT) for prostate cancer on the sexual function-related quality of life of patients and their partners. Methods and Materials: Sixty of 124 consecutive patients (median age 72.3 years) treated with 3D CRT for localized prostate cancer were surveyed and reported being potent prior to treatment. The answers to survey questions assessing the impact of quality of life related to sexual function from these 60 patients and their partners forms the basis for this retrospective analysis. Results: Following 3D CRT, 37 of 60 patients (62%) retained sexual function sufficient for intercourse. Intercourse at least once per month was reduced from 71 to 40%, whereas intercourse less than once per year increased from 12 to 35%. Following treatment, 25% of patients reported that the change in sexual dysfunction negatively affected their relationship or resulted in poor self-esteem. This outcome was associated with impotence following treatment (p < 0.01). Patients who had partners and satisfactory sexual function appeared to be at a higher risk of having a negatively affected relationship or losing self- esteem if they become impotent (p < 0.05). Partners of patients who reported a negatively affected relationship or loss of self-esteem appear to be less likely to return the survey instrument used (p = 0.02). Conclusions: More work is needed to evaluate the impact of radiotherapy and other treatments on the quality of life of patients and their partners to allow adequate informed consent to be given.

KW - Conformal radiation therapy

KW - Impotence

KW - Prostate cancer

KW - Quality of life

KW - Sexual dysfunction

UR - http://www.scopus.com/inward/record.url?scp=0030586082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030586082&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(96)00206-4

DO - 10.1016/0360-3016(96)00206-4

M3 - Article

C2 - 8751394

AN - SCOPUS:0030586082

VL - 35

SP - 869

EP - 874

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -